Norcross L - Search Results

1

A Review of Patient-Reported Outcome Considerations in Oncologic Drugs Advisory Committee Meetings (2016-2021).

Gnanasakthy A, Norcross L, Clark M, Fitzgerald K. Gnanasakthy A, et al. Among authors: norcross l. JCO Oncol Pract. 2023 May;19(5):e745-e762. doi: 10.1200/OP.22.00774. Epub 2023 Feb 28. JCO Oncol Pract. 2023. PMID: 36854073 Review.

2

Use of Patient and Investigator Global Impression Scales: A Review of Food and Drug Administration-Approved Labeling, 2009 to 2019.

Gnanasakthy A, Barrett A, Norcross L, D'Alessio D, Romano CD. Gnanasakthy A, et al. Among authors: norcross l. Value Health. 2021 Jul;24(7):1016-1023. doi: 10.1016/j.jval.2021.01.005. Epub 2021 Apr 1. Value Health. 2021. PMID: 34243825 Free article.

3

A Review of Patient-Reported Outcome Labeling of FDA-Approved New Drugs (2016-2020): Counts, Categories, and Comprehensibility.

Gnanasakthy A, Norcross L, DeMuro Romano C, Carson RT. Gnanasakthy A, et al. Among authors: norcross l. Value Health. 2022 Apr;25(4):647-655. doi: 10.1016/j.jval.2021.10.006. Epub 2021 Dec 24. Value Health. 2022. PMID: 35365309 Free article. Review.

4

FDA Guidance on Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments: Old Wine in a New Bottle?

Gnanasakthy A, Qin S, Norcross L. Gnanasakthy A, et al. Among authors: norcross l. Patient. 2023 Jan;16(1):3-5. doi: 10.1007/s40271-022-00607-6. Epub 2022 Oct 19. Patient. 2023. PMID: 36260202 No abstract available.

5

A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021).

Gnanasakthy A, Levy C, Norcross L, Doward L, Winnette R. Gnanasakthy A, et al. Among authors: norcross l. Value Health. 2023 Jun;26(6):893-901. doi: 10.1016/j.jval.2023.01.017. Epub 2023 Feb 4. Value Health. 2023. PMID: 36746305 Free article. Review.

6

Assessment of Patient-Reported Outcomes in Industry-Sponsored Phase I Oncology Studies: Considerations for Translating Theory Into Practice.

Gnanasakthy A, Norcross L, Fitzgerald K. Gnanasakthy A, et al. Among authors: norcross l. Value Health. 2023 Oct;26(10):1440-1443. doi: 10.1016/j.jval.2023.06.006. Epub 2023 Jun 21. Value Health. 2023. PMID: 37353056 Free article.

7

Critical Comments by Food and Drug Administration Reviewers on Patient-Reported Outcomes in Food and Drug Administration Regulatory Submissions (2018-2021).

Slota C, Norcross L, Comerford E, Sasane M, Zheng Y, Gnanasakthy A. Slota C, et al. Among authors: norcross l. Value Health. 2024 Jun;27(6):755-766. doi: 10.1016/j.jval.2024.02.011. Epub 2024 Mar 6. Value Health. 2024. PMID: 38458563

8

[No title available]

[No authors listed] [No authors listed] PMID: 38580230

9

Pulmonary hypertension due to interstitial lung disease or chronic obstructive pulmonary disease: a patient experience study of symptoms and their impact on quality of life.

DuBrock HM, Nathan SD, Reeve BB, Kolaitis NA, Mathai SC, Classi PM, Nelsen AC, Olayinka-Amao B, Norcross LN, Martin SA. DuBrock HM, et al. Pulm Circ. 2021 Apr 1;11(2):20458940211005641. doi: 10.1177/20458940211005641. eCollection 2021 Apr-Jun. Pulm Circ. 2021. PMID: 33868642 Free PMC article.

10

Interview-Based Patient- and Caregiver-Reported Experiences of Hunger and Improved Quality of Life with Setmelanotide Treatment in Bardet-Biedl Syndrome.

Ervin C, Norcross L, Mallya UG, Fehnel S, Mittleman RS, Webster M, Haqq AM, Haws RM. Ervin C, et al. Among authors: norcross l. Adv Ther. 2023 May;40(5):2394-2411. doi: 10.1007/s12325-023-02443-y. Epub 2023 Mar 24. Adv Ther. 2023. PMID: 36961653 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters